{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:35:50Z","timestamp":1771504550054,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ophtha.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T12:52:31Z","timestamp":1366203151000},"page":"1521-1528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Microbial Colonization and Antibacterial Resistance Patterns after Boston Type 1 Keratoprosthesis"],"prefix":"10.1016","volume":"120","author":[{"given":"Marie-Claude","family":"Robert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie Patrice","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Saint-Antoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Harissi-Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2013.01.003_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.iio.0000176365.71016.28","article-title":"Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure","volume":"45","author":"Ma","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2013.01.003_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003226-200101000-00003","article-title":"Keratoprosthesis: preoperative prognostic categories","volume":"20","author":"Yaghouti","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ophtha.2008.12.058","article-title":"The Boston type 1 keratoprosthesis: improving outcomes and expanding indications","volume":"116","author":"Aldave","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0b013e31818b8bfa","article-title":"Boston type 1 keratoprosthesis: the University of California Davis experience","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3181a186dc","article-title":"Boston keratoprosthesis outcomes and complications","volume":"28","author":"Chew","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ophtha.2006.05.015","article-title":"Results from the multicenter Boston type 1 keratoprosthesis study","volume":"113","author":"Zerbe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ophtha.2009.09.024","article-title":"Short-term visual outcomes of Boston type 1 keratoprosthesis implantation","volume":"117","author":"Dunlap","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3129\/i10-103","article-title":"Boston type 1 keratoprosthesis: the CHUM experience","volume":"46","author":"Robert","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2012.02.015","article-title":"International results with the Boston type I keratoprosthesis","volume":"119","author":"Aldave","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/eye.2011.325","article-title":"Boston type 1 keratoprosthesis: the New York Eye and Ear experience","volume":"26","author":"Patel","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2013.01.003_bib11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/ICO.0b013e3181d2ce25","article-title":"In\u00a0vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics","volume":"29","author":"Elsahn","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jcrs.2010.06.028","article-title":"Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones","volume":"36","author":"McDonald","year":"2010","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2013.01.003_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/ICO.0b013e31819b0385","article-title":"Characteristics of endophthalmitis in patients with the Boston keratoprosthesis","volume":"28","author":"Fintelmann","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.119.4.484","article-title":"Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors","volume":"119","author":"Nouri","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/17469899.1.1.41","article-title":"Introduction to the use of the Boston keratoprosthesis","volume":"1","author":"Dohlman","year":"2006","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","article-title":"The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence","volume":"37","author":"Svarstad","year":"1999","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.ophtha.2013.01.003_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/ICO.0b013e3182114467","article-title":"The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency","volume":"30","author":"Sejpal","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/ICO.0b013e318245c02a","article-title":"Infectious keratitis after Boston type 1 keratoprosthesis implantation","volume":"31","author":"Chan","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/ICO.0b013e3181ca2ea5","article-title":"Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography","volume":"29","author":"Garcia","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib21","article-title":"Boston KPro news","volume":"1","year":"2011","journal-title":"Fall"},{"key":"10.1016\/j.ophtha.2013.01.003_bib22","first-page":"1","article-title":"The Boston Keratoprosthesis","volume":"5","author":"Harissi-Dagher","year":"2006","journal-title":"Contemp Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ophtha.2011.10.009","article-title":"Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis","volume":"119","author":"Ramchandran","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/ICO.0b013e3181983982","article-title":"Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis","volume":"28","author":"Durand","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.ico.0000224650.19837.25","article-title":"Fungal colonization and infection in Boston keratoprosthesis","volume":"26","author":"Barnes","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ICO.0b013e31821eea2f","article-title":"Infectious endophthalmitis after Boston\u00a0type 1 keratoprosthesis implantation","volume":"31","author":"Chan","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib27","series-title":"Ocular Anesthesia","first-page":"105","article-title":"Anesthesia for corneal surgery","author":"Ingraham","year":"1997"},{"key":"10.1016\/j.ophtha.2013.01.003_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1026567912389","article-title":"The antibacterial effect of topical anesthetic proparacaine on conjunctival flora","volume":"23","author":"Oguz","year":"1999","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ICO.0b013e318182259b","article-title":"The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics","volume":"28","author":"Park","year":"2009","journal-title":"Cornea"},{"issue":"suppl","key":"10.1016\/j.ophtha.2013.01.003_bib30","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archophthalmol.2011.45","article-title":"Topical fluoroquinolone use as a risk factor for in\u00a0vitro fluoroquinolone resistance in ocular cultures","volume":"129","author":"Fintelmann","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib32","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib33","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ophtha.2011.03.017","article-title":"Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study","volume":"118","author":"Dave","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.2011.0072","article-title":"Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones","volume":"28","author":"Segreti","year":"2012","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2013.01.003_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bjo.2005.068981","article-title":"Topical ocular antibiotics induce bacterial resistance at extraocular sites","volume":"89","author":"Gaynor","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.01.003_bib36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2010.12.014","article-title":"Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections","volume":"118","author":"Kim","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib37","article-title":"Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine","author":"Magalh\u00e3es","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.01.003_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ophtha.2011.09.034","article-title":"Keratoprosthesis surveillance cultures [letter]","volume":"119","author":"Yu","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.01.003_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/jop.2006.0137","article-title":"Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use","volume":"23","author":"Ward","year":"2007","journal-title":"J\u00a0Ocul Pharmacol Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:04:24Z","timestamp":1758981864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642013000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0161642013000055"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.003","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial Colonization and Antibacterial Resistance Patterns after Boston Type 1 Keratoprosthesis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}